Related Experiment Video
Updated: May 7, 2026
11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
21.6K
Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation in a Pediatric Patient
Fuqiang Liu1, Yimin Hua1, Yifei Li2,3
1Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Pediatric Cardiology
|May 6, 2026
Summary
This study details a successful cardiac pulsed-field ablation (PFA) for a 12-year-old with paroxysmal atrial fibrillation (AF). PFA shows promise as a superior treatment for young patients with AF.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Technology
Background:
- Paroxysmal atrial fibrillation (AF) can be symptomatic and debilitating.
- Catheter ablation is a common treatment for AF.
- Novel ablation technologies are needed, especially for pediatric patients.
Purpose of the Study:
- To report the first documented case of successful catheter ablation for paroxysmal AF in a pediatric patient using cardiac pulsed-field ablation (PFA) technology.
- To evaluate the feasibility and efficacy of PFA in a young patient population.
Main Methods:
- A 12-year-old male with symptomatic paroxysmal AF underwent catheter ablation.
- Cardiac pulsed-field ablation (PFA) technology (LEAD-PFA, JJET) was employed.
- A systematic lesion creation protocol targeted pulmonary veins and surrounding regions.
Main Results:
- Atrial fibrillation (AF) was induced during the procedure but terminated post-ablation.
- Successful pulmonary vein isolation was achieved using PFA.
- The procedure was technically successful without immediate complications.
Conclusions:
- Catheter ablation using PFA technology is a viable option for treating paroxysmal AF in pediatric patients.
- PFA may offer advantages over traditional ablation methods in young individuals.
- Further research is warranted to establish PFA as a standard therapy for pediatric AF.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
1.2K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
01:23Cardiopulmonary Resuscitation III: AED Use
1.7K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
01:29Disturbances in Heart Rhythm
5.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.5K
01:25Dysrhythmias VI: Management of Dysrhythmias
599
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
599
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.7K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788